Rosemary Mazanet's Net Worth
$790 Thousand
Who is Rosemary Mazanet?
Rosemary Mazanet does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cannabist Co Holdings Inc., GALENA BIOPHARMA, INC., Actinium Pharmaceuticals, Inc., Oncternal Therapeutics, Inc., ACCESS PHARMACEUTICALS INC, and AKSYS LTD.
SEC CIK
Rosemary Mazanet's CIK is 0001276892
Past Insider Trading and Trends
2007 was Rosemary Mazanet's most active year for acquiring shares with 9 total transactions. Rosemary Mazanet's most active month to acquire stocks was the month of March. 2022 was Rosemary Mazanet's most active year for disposing of shares, totalling 8 transactions. Rosemary Mazanet's most active month to dispose stocks was the month of March. 2007 saw Rosemary Mazanet paying a total of $474,260.10 for 109,436.33 shares, this is the most they've acquired in one year. In 2022 Rosemary Mazanet cashed out on 254,807 shares for a total of $170,237.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cannabist Co Holdings Inc. (CBSTF) Snapshot price: $0.2136
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.78% | 37.71K |
—
|
—
| 2.15M |
Apr 23
| |||
Form 4
| +20.75% | 363.64K |
—
|
—
| 2.12M |
Apr 5
| |||
Form 4
| +14.14% | 217.15K |
—
|
—
| 1.75M |
Mar 31
| |||
Form 4
| +1.20% | 18.17K |
—
|
—
| 1.54M |
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
| +0.97% | 14.59K |
$0.48 | -$2,131.68 | 1.52M |
Jul 5
| |||
Form 4
| +4.73% | 67.83K |
$0.49 | -$21,026.39 | 1.5M |
May 3
| |||
Form 4
| +7.89% | 104.98K |
$0.52 | -$37,431.16 | 1.43M |
Apr 11
| |||
Form 4
| +2.16% | 28.06K |
$0.74 | -$11,454.46 | 1.33M |
Dec 23
| |||
Form 4
| +1.16% | 14.89K |
$1.39 | -$11,385.49 | 1.3M |
Oct 18
| |||
Form 4
| +6.66% | 80.4K |
$2.75 | -$147,397.25 | 1.29M |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GALENA BIOPHARMA, INC. (SLS) Snapshot price: $1.16
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $1.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 100 |
$3.95 | $395.00 | 100 |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
| +0.39% | 89.07 |
$16.84 | $1,499.94 | 22.78K |
Dec 31
| |||
Form 4
| +1.71% | 381.17 |
$19.02 | $7,249.85 | 22.69K |
Sep 30 - Oct 1
| |||
Form 4
| +2.32% | 505.22 |
$14.35 | $7,249.91 | 22.31K |
Jun 30 - Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +0.21% | 497.51 |
$16.08 | $7,999.96 | 233.3K |
Mar 31 - Apr 1
| |||
Form 4
| +2.43% | 505.22 |
$14.35 | $7,249.91 | 21.31K |
Dec 31 - Jan 1
| |||
Form 4
| +2.19% | 445.34 |
$16.28 | $7,250.14 | 20.8K |
Sep 30 - Oct 1
| |||
Form 4
| +1.54% | 308.83 |
$16.19 | $4,999.96 | 20.36K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +1.24% | 245.1 |
$20.40 | $5,000.04 | 20.05K |
Apr 1
| |||
Form 4
| +1.44% | 280.27 |
$17.84 | $5,000.02 | 19.8K |
Jan 1
| |||
Form 4
| +2.85% | 541.13 |
$9.24 | $5,000.04 | 19.52K |
Oct 1
| |||
Form 4
| +2.98% | 549.45 |
$9.10 | $5,000.00 | 18.98K |
Jul 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
| +2.55% | 457.88 |
$10.92 | $5,000.05 | 18.43K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
| +3.82% | 661.38 |
$7.56 | $5,000.03 | 17.98K |
Jan 1
| |||
Form 4
| +3.20% | 537.06 |
$9.31 | $5,000.03 | 17.31K |
Sep 30
| |||
Form 4
| +3.09% | 503.02 |
$9.94 | $5,000.02 | 16.78K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +3.49% | 549.45 |
$9.10 | $5,000.00 | 16.27K |
Apr 1
| |||
Form 4
| +8.75% | 1.26K |
$11.86 | $14,999.88 | 15.72K |
Jul 1 - Jan 1
| |||
Form 4
|
∞
| 14.46K |
—
|
—
| 14.46K |
Aug 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCESS PHARMACEUTICALS INC (ABEO) Snapshot price: $5.55
Acting Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||